A University of Colorado Boulder-led team has discovered two prime
targets of the Hepatitis B virus in liver cells, findings that could
lead to treatment of liver disease in some of the 400 million people
worldwide currently infected with the virus.
CU-Boulder Professor Ding Xue, who led the studies, said scientists
have been looking for cellular targets of the Hepatitis B virus, or HBV,
for more than three decades. Infections from HBV promote hepatitis
(inflammation of the liver), cirrhosis (scarring of the liver) and liver
cancer and can be transmitted through blood and bodily fluids,
unprotected sex, unsterile needles and from infected mother to offspring
during birth.
Read more....
No comments:
Post a Comment